tiprankstipranks
Kissei Pharmaceutical Co Ltd (JP:4547)
:4547
Japanese Market
4547
Kissei Pharmaceutical Co
RESEARCH TOOLSreports
Want to see JP:4547 full AI Analyst Report?

Kissei Pharmaceutical Co (4547) Ratios

0 Followers

Kissei Pharmaceutical Co Ratios

JP:4547's free cash flow for Q1 2026 was ¥0.50. For the 2026 fiscal year, JP:4547's free cash flow was decreased by ¥ and operating cash flow was ¥0.26. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 26Mar 25Mar 24
Liquidity Ratios
Current Ratio
 5.30 6.45 5.30 5.92 6.73
Quick Ratio
 4.12 4.95 4.12 4.43 5.20
Cash Ratio
 1.34 1.52 1.34 1.30 1.73
Solvency Ratio
 0.42 0.49 0.42 0.39 0.55
Operating Cash Flow Ratio
 0.00 0.39 -0.07 -0.09 -0.45
Short-Term Operating Cash Flow Coverage
 0.00 4.56 -1.19 -1.25 -4.48
Net Current Asset Value
¥ 71.42B¥ 73.05B¥ 71.42B¥ 64.76B¥ 74.25B
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.20 1.17 1.20 1.19 1.14
Debt Service Coverage Ratio
 12.58 11.44 -0.95 11.46 9.78
Interest Coverage Ratio
 -104.50 274.90 -104.50 223.17 -56.45
Debt to Market Cap
 <0.01 <0.01 <0.01 <0.01 0.01
Interest Debt Per Share
 30.86 37.09 30.75 30.01 32.74
Net Debt to EBITDA
 -1.46 -1.16 -16.19 -1.15 -1.37
Profitability Margins
Gross Profit Margin
47.04%49.89%47.04%49.41%47.97%
EBIT Margin
14.76%17.70%-3.00%19.14%20.30%
EBITDA Margin
19.52%22.92%1.76%24.77%26.38%
Operating Profit Margin
-3.00%6.54%-3.00%5.31%-1.67%
Pretax Profit Margin
17.34%17.67%17.34%19.12%20.27%
Net Profit Margin
14.14%13.54%14.15%14.77%15.60%
Continuous Operations Profit Margin
14.33%13.56%14.33%14.94%15.76%
Net Income Per EBT
81.58%76.63%81.58%77.24%76.96%
EBT Per EBIT
-577.20%270.38%-577.27%359.70%-1211.69%
Return on Assets (ROA)
5.01%4.90%5.01%4.28%4.76%
Return on Equity (ROE)
6.37%5.72%5.99%5.07%5.43%
Return on Capital Employed (ROCE)
-1.15%2.54%-1.15%1.65%-0.55%
Return on Invested Capital (ROIC)
-0.95%1.93%-0.95%1.28%-0.42%
Return on Tangible Assets
5.04%4.94%5.05%4.31%4.79%
Earnings Yield
8.55%7.13%7.13%7.12%8.64%
Efficiency Ratios
Receivables Turnover
 3.08 2.98 3.08 2.64 2.96
Payables Turnover
 7.74 9.62 7.74 7.81 7.61
Inventory Turnover
 2.02 1.77 2.02 1.45 1.54
Fixed Asset Turnover
 3.47 3.26 3.47 3.04 2.75
Asset Turnover
 0.35 0.36 0.35 0.29 0.31
Working Capital Turnover Ratio
 1.08 1.00 1.06 0.88 0.81
Cash Conversion Cycle
 251.79 290.56 251.79 342.80 312.30
Days of Sales Outstanding
 118.34 122.53 118.34 138.50 123.33
Days of Inventory Outstanding
 180.57 205.97 180.57 251.01 236.95
Days of Payables Outstanding
 47.13 37.95 47.13 46.71 47.99
Operating Cycle
 298.92 328.50 298.92 389.51 360.29
Cash Flow Ratios
Operating Cash Flow Per Share
 0.00 149.49 -35.73 -37.05 -144.83
Free Cash Flow Per Share
 0.00 46.17 -153.22 -77.56 -200.07
CapEx Per Share
 0.00 103.32 117.49 40.50 55.23
Free Cash Flow to Operating Cash Flow
 0.00 0.31 4.29 2.09 1.38
Dividend Paid and CapEx Coverage Ratio
 0.00 0.78 -0.15 -0.30 -1.18
Capital Expenditure Coverage Ratio
 0.00 1.45 -0.30 -0.91 -2.62
Operating Cash Flow Coverage Ratio
 0.00 4.08 -1.19 -1.25 -4.48
Operating Cash Flow to Sales Ratio
 0.00 0.07 -0.02 -0.02 -0.10
Free Cash Flow Yield
0.00%1.20%-3.29%-2.24%-7.58%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 11.56 14.02 14.03 14.05 11.57
Price-to-Sales (P/S) Ratio
 1.64 1.90 1.98 2.07 1.80
Price-to-Book (P/B) Ratio
 0.69 0.80 0.84 0.71 0.63
Price-to-Free Cash Flow (P/FCF) Ratio
 0.00 83.28 -30.35 -44.68 -13.20
Price-to-Operating Cash Flow Ratio
 0.00 25.72 -130.14 -93.51 -18.23
Price-to-Earnings Growth (PEG) Ratio
 0.56 1.25 0.67 1.75 -0.62
Price-to-Fair Value
 0.69 0.80 0.84 0.71 0.63
Enterprise Value Multiple
 6.92 7.12 96.31 7.23 5.47
Enterprise Value
 133.44B 144.15B 165.46B 135.26B 97.39B
EV to EBITDA
 7.02 7.12 96.31 7.23 5.47
EV to Sales
 1.37 1.63 1.70 1.79 1.44
EV to Free Cash Flow
 0.00 71.58 -25.98 -38.54 -10.56
EV to Operating Cash Flow
 0.00 22.11 -111.42 -80.66 -14.58
Tangible Book Value Per Share
 5.54K 4.77K 5.52K 4.84K 4.19K
Shareholders’ Equity Per Share
 5.56K 4.79K 5.54K 4.86K 4.20K
Tax and Other Ratios
Effective Tax Rate
 0.17 0.23 0.17 0.22 0.22
Revenue Per Share
 2.35K 2.02K 2.34K 1.67K 1.46K
Net Income Per Share
 332.67 274.20 331.53 246.59 228.30
Tax Burden
 0.82 0.77 0.82 0.77 0.77
Interest Burden
 1.17 1.00 -5.77 1.00 1.00
Research & Development to Revenue
 0.00 0.15 0.00 0.13 0.15
SG&A to Revenue
 0.50 0.25 0.50 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.00 0.55 -0.11 -0.15 -0.49
Currency in JPY